Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Single-Arm, Multiple-Dose, Phase 3 Safety and Efficacy Study of Cebranopadol in Participants With Moderate to Severe Acute Pain With Surgical or Non-Surgical Origin

NCT07845071 is registered in ClinicalTrials.gov with Adneuris Therapeutics, Inc. as lead sponsor.

NCT NCT07845071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07845071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Single-Arm, Multiple-Dose, Phase 3 Safety and Efficacy Study of Cebranopadol in Participants With Moderate to Severe Acute Pain With Surgical or Non-Surgical Origin
Lead sponsor
Adneuris Therapeutics, Inc.
Phase
Phase 3
Overall status
Recruiting
Start date
September 22, 2026
Completion date
February 28, 2027
Enrollment
160 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

pain